A Study in Patients with Myasthenia Gravis in China

Trial Identifier: D9030R00001
Sponsor: AstraZeneca
Start Date: September 2024
Primary Completion Date: December 2027
Study Completion Date: December 2027
Condition: Myasthenia Gravis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China
China chengdu, China
China Fuzhou, China
China Guangzhou, China
China Guiyang, China
China Harbin, China
China Hebei, China
China Henan, China
China Inner Mongolia, China
China Jiangsu, China
China Lanzhou, China
China Nanning, China
China Qingdao, China
China Taiyuan, China
China Tianjin, China
China Urumqi, China
China Wenzhou, China
China Wuhan, China
China Xi an, China
China Xi'an, China
China Yinchuan, China